V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240007441 | 240004625 | null | 85.6 | Palliative (P) | 2013-06-07 | 2013-06-12 | CARBOPLATIN | N | N | 240033540 | CARBOPLATIN |
| 240007442 | 240004626 | 1.75 | 90 | Curative (C) | 2014-08-20 | 2014-08-29 | INTERLACE TRIAL | N | N | 240033545 | INTERLACE TRIAL |
| 240007443 | 240004626 | 1.53 | 137.6 | Curative (C) | 2014-09-22 | 2014-09-22 | Chlorambucil | 2 | N | 240033545 | CHLORAMBUCIL |
| 240007444 | 240004627 | 1.74 | 22.9 | Not known (9) | null | 2017-03-01 | Carboplatin AUC 2 - 5 | 02 | N | 240033561 | CARBOPLATIN |
| 240007445 | 240010578 | 0 | 49 | Palliative (P) | 2013-11-21 | 2013-12-03 | Chlorambucil | N | N | 240033562 | CHLORAMBUCIL |
| 240007446 | 240004628 | 1.62 | null | Not known (9) | 2015-06-21 | 2015-07-02 | Trial Unspecified | N | N | 240033568 | TRIAL |
| 240007447 | 240004628 | null | 70.8 | Curative (C) | 2016-12-07 | 2017-01-03 | ALCL ALCL 99 Closed Pre Phase | null | N | 240033568 | NOT MATCHED |
| 240007448 | 240004629 | 0 | 74.9 | Neo-adjuvant (N) | 2017-03-20 | 2017-03-27 | null | N | N | 240033573 | NOT MATCHED |
| 240007449 | 240004630 | null | 80.1 | Palliative (P) | 2016-05-25 | 2016-06-08 | R Chlorambucil | N | N | 240033580 | CHLORAMBUCIL + RITUXIMAB |
| 240007450 | 240004630 | 1.6 | 88 | Palliative (P) | 2016-08-10 | 2016-08-29 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240033580 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007451 | 240004630 | 1.66 | 59.2 | Disease modification (D) | 2013-05-17 | 2013-06-15 | Carboplatin AUC 6 - 10 | 02 | N | 240033580 | CARBOPLATIN |
| 240007452 | 240004631 | 1.56 | 66.6 | Palliative (P) | 2016-10-07 | 2016-10-11 | null | 01 | N | 240033592 | NOT MATCHED |
| 240007453 | 240004632 | 1.55 | 61.4 | Palliative (P) | null | 2014-09-17 | Carboplatin AUC 2 - 5 | N | N | 240033601 | CARBOPLATIN |
| 240007454 | 240004632 | 1.6 | 80 | Palliative (P) | 2016-11-08 | 2016-12-04 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240033601 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007455 | 240013515 | null | 0 | Disease modification (D) | 2016-09-16 | 2016-09-17 | Bendamustine +/- Prednisolone | 99 | null | 240033604 | BENDAMUSTINE |
| 240007456 | 240004633 | 1.65 | 69.4 | null | 2015-12-31 | 2015-12-31 | CHLORAMBUCIL + RITUXIMAB | N | N | 240033606 | CHLORAMBUCIL + RITUXIMAB |
| 240007457 | 240004633 | 1.7 | 0 | Disease modification (D) | null | 2017-06-16 | Chlorambucil | 02 | N | 240033606 | CHLORAMBUCIL |
| 240007458 | 240004634 | null | 68.5 | Disease modification (D) | 2018-09-21 | 2018-09-27 | Chlorambucil | N | N | 240033611 | CHLORAMBUCIL |
| 240007459 | 240010583 | null | null | Palliative (P) | 2017-11-03 | 2017-12-04 | Bevacizumab+Carbo+Pacliaxel | N | N | 240033612 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007460 | 240013516 | null | 92.6 | null | 2016-02-24 | 2016-02-24 | CHLORAMBUCIL + RITUXIMAB | 02 | N | 240033615 | CHLORAMBUCIL + RITUXIMAB |
| 240007461 | 240004635 | null | 52.9 | Curative (C) | 2016-12-04 | 2016-12-15 | DA 3 + 10 | 1 | N | 240033623 | DA |
| 240007462 | 240004636 | 1.68 | 80.1 | Not known (9) | 2013-07-16 | 2013-08-07 | Bevacizumab+Carbo+Pacliaxel | N | N | 240033624 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007463 | 240004637 | 1.57 | 109.7 | Adjuvant (A) | 2018-01-15 | 2018-02-06 | Carboplatin + Etoposide iv&po | Y | Y | 240033629 | CARBOPLATIN + ETOPOSIDE |
| 240007467 | 240004639 | 1.63 | null | Curative (C) | 2013-07-23 | 2013-08-05 | DA 3 + 10 | null | null | 240033642 | DA |
| 240007468 | 240004639 | null | 0 | Curative (C) | 2014-01-31 | 2014-02-02 | INTERLACE TRIAL | N | N | 240033642 | INTERLACE TRIAL |
| 240007469 | 240004640 | 1.56 | 72.3 | Disease modification (D) | 2017-07-23 | 2017-07-24 | Trial Unspecified | N | N | 240033648 | TRIAL |
| 240007470 | 240004641 | null | 91.3 | Palliative (P) | 2012-04-22 | 2012-04-28 | Chlorambucil | N | N | 240033649 | CHLORAMBUCIL |
| 240007471 | 240004642 | 0 | 78 | Curative (C) | 2015-11-23 | 2015-11-23 | null | N | N | 240033654 | NOT MATCHED |
| 240007472 | 240004643 | null | 72.2 | Palliative (P) | 2014-12-04 | 2014-12-09 | Bevacizumab + CARBOPLATIN + PACLITAXEL | Y | N | 240033657 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007473 | 240004644 | 1.59 | null | Curative (C) | 2016-03-23 | 2016-03-23 | Trial Unspecified | 2 | null | 240033658 | TRIAL |
| 240007474 | 240004644 | 1.77 | 107.1 | Palliative (P) | 2015-08-08 | 2015-08-25 | Bendamustine +/- Prednisolone | N | N | 240033658 | BENDAMUSTINE |
| 240007475 | 240004645 | null | null | Curative (C) | 2013-05-11 | 2013-05-27 | Carboplatin AUC 2 - 5 | null | null | 240033666 | CARBOPLATIN |
| 240007476 | 240004646 | null | null | Neo-adjuvant (N) | 2016-12-15 | 2016-12-23 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine + RITUXIMAB | N | null | 240033668 | NOT MATCHED |
| 240007477 | 240004647 | 1.68 | 80 | Palliative (P) | 2016-04-05 | 2016-04-18 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240033672 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007478 | 240004648 | 1.84 | 68 | Disease modification (D) | 2015-02-13 | 2015-02-20 | R Chlorambucil | N | N | 240033675 | CHLORAMBUCIL + RITUXIMAB |
| 240007479 | 240004649 | 1.62 | 0 | Curative (C) | 2014-12-27 | 2015-01-07 | Trial Unspecified | N | N | 240033677 | TRIAL |
| 240007480 | 240004649 | 1.58 | 89 | Palliative (P) | 2016-03-25 | 2016-04-14 | Chlorambucil + Pred + Rituximab | Y | Y | 240033677 | CHLORAMBUCIL + RITUXIMAB |
| 240007481 | 240004650 | 1.58 | 44.2 | Not known (9) | 2015-01-12 | 2015-01-13 | Trial Unspecified | N | N | 240033681 | TRIAL |
| 240007482 | 240010588 | 1.56 | null | null | 2017-08-16 | 2017-08-24 | Bendamustine +/- Prednisolone | 99 | null | 240033682 | BENDAMUSTINE |
| 240007483 | 240010588 | null | 55.9 | Curative (C) | 2015-03-23 | 2015-03-30 | null | null | null | 240033682 | NOT MATCHED |
| 240007484 | 240010588 | 1.68 | 63.5 | Curative (C) | 2015-06-25 | 2015-07-03 | CYTARABINE + DAUNORUBICIN | 02 | N | 240033682 | DA |
| 240007485 | 240004651 | 1.66 | 64.2 | Palliative (P) | 2018-10-02 | 2018-10-05 | Hydroxycarbamide | 02 | N | 240033692 | HYDROXYCARBAMIDE |
| 240007486 | 240010589 | 1.63 | 80.2 | Curative (C) | 2014-12-07 | 2014-12-10 | DA 3 + 10 | N | N | 240033693 | DA |
| 240007487 | 240004652 | 1.51 | null | Neo-adjuvant (N) | 2017-05-16 | 2017-05-16 | null | null | null | 240033694 | NOT MATCHED |
| 240007488 | 240004652 | 1.7 | 60 | Disease modification (D) | null | 2014-11-25 | R Chlorambucil | 2 | N | 240033694 | CHLORAMBUCIL + RITUXIMAB |
| 240007489 | 240004653 | 1.8 | 79.5 | Curative (C) | 2013-07-25 | 2013-07-29 | DA 3+8 | N | N | 240033697 | DA |
| 240007490 | 240004653 | 1.59 | 65 | Curative (C) | 2015-01-03 | 2015-01-03 | CYTARABINE + DAUNORUBICIN | N | N | 240033697 | DA |
| 240007491 | 240004653 | 1.67 | 85.4 | null | 2014-01-07 | 2014-01-16 | CHLORAMBUCIL + RITUXIMAB | 02 | N | 240033697 | CHLORAMBUCIL + RITUXIMAB |
| 240007492 | 240004654 | 1.74 | 101.5 | Palliative (P) | null | 2013-09-16 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | null | 240033707 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007493 | 240004654 | 1.78 | 63.4 | Palliative (P) | 2014-01-01 | 2014-01-01 | Hydroxycarbamide | 01 | N | 240033707 | HYDROXYCARBAMIDE |